Callan Family Office’s RAPT Therapeutics RAPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,166	Closed	-$109K	–	938
2025 Q1	$109K	Buy	11,166 +3,911	+54%	+$38.2K	0.01%	533
2024 Q4	$91.7K	Buy	+7,255	New	+$91.7K	0.01%	618